Noida, UP -- (SBWIRE) -- 11/29/2013 -- Diabetes is one of the promising therapeutic segments in UK injectable market. In 1996 approximately 1.6 Million people were diagnosed with diabetes, it has reached 3 Million now. The disease has become widespread across the country with a current prevalence rate of approximately 4.6%. Such remarkable increasing prevalence of diabetics in UK has prompted pharmaceutical players to innovate technologically advanced products. Apart from this, several small pharmaceutical companies has started offering diabetes injectables. Due to this the demand for insulin injectables throughout the country tends to increase. Promising researches have been confronted by the country’s team of scientists to aid the treatment of diabetes via injectables. Besides, a lot of investment has been undertaken by UK government to promote the growth of insulin injectables.

The report, “UK Injectables Market Outlook to 2017”, is spread across 40 pages provides an in-depth research and rational analysis of injectable drugs sold in UK. On account of our analysis of the past and present prevalence statistics for major indications and private sector developments, forecast for injectable market have been drawn. Our research clearly depicts the historic, current, and expected revenue trend analysis across the country, size of injectable market in the country and of course, the key drivers and restraints encompassing the Injectable drug market. Government initiatives to boost injectable drug business have also been studied. In order to understand the competition, we have profiled key players covering their business overview and product portfolios. Strategies adopted by key market players are also included in the report to give a pragmatic market insight to the investors and stakeholders.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM634.htm

Some of our Related Reports are:

- Global API Market Forecast to 2017 (http://rncos.com/Report/IM612.htm)
- Personalized Medicine Market Analysis (http://www.rncos.com/Report/IM305.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.